AI-Based Clinical Trial Solution Providers Market Analysis
The Business Research Company recently released a comprehensive report on the Global AI-Based Clinical Trial Solution Providers Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company’s, The ai-based clinical trial solution providers market size has grown exponentially in recent years. It will grow from $2 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increased complexity in clinical trials, growing volume of clinical trial data, regulatory compliance challenges, drug discovery and development demands, personalized medicine trends.
The ai-based clinical trial solution providers market size is expected to see exponential growth in the next few years. It will grow to $5.65 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to integration with real-world evidence (rwe), advancements in natural language processing (nlp), decentralized clinical trials adoption, expansion of therapeutic areas, enhanced predictive analytics. Major trends in the forecast period include collaboration with biotech and pharma companies, patient-centric approaches, predictive analytics for trial design, real-world evidence integration, blockchain for data security.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report
Market Drivers and Trends:
The increasing adoption of AI technology is expected to propel the growth of the AI-based clinical trial solution provider market going forward. Artificial intelligence (AI) refers to the development of computer systems or software that can perform tasks that typically require human intelligence. AI technology is being increasingly used by clinical trial solution providers to bring efficiency, accuracy, and innovation to various stages of the clinical trial lifecycle, ultimately contributing to improved patient outcomes and advancements in medical research. For instance, in May 2022, according to The International Business Machines Corporation (IBM), a US-based technology corporation, the adoption rate of AI globally increased significantly by 35%, up four points from the previous year. Further, in 2022, 13% more firms are projected to have used AI than in 2021, and around 35% of organizations reported adopting AI in their company, 42% are considering AI for adoption, and two-thirds of the companies (66%) are either presently executing or intending to utilize AI to meet their sustainability goals. Therefore, the increasing adoption of AI technology is driving the growth of the AI-based clinical trial solution provider market.
Major companies operating in the AI-based clinical trial solution providers market are developing innovative technological innovations in the market, such as the Saama AI-driven data platform, to accelerate clinical development and strengthen their position in the market. An AI-driven data platform is a software solution that leverages artificial intelligence (AI) and machine learning (ML) to automate and enhance various data management and analysis processes. For instance, In June 2023, Saama Technologies, Inc., a US-based software company, introduced an AI-driven data platform called Saama. An AI-driven data platform streamlines clinical trial processes by centralizing and standardizing data, offering real-time insights into trial operations, financials, and patient data. The platform utilizes AI and advanced analytics to automate tasks, enhance productivity, and provide deep insights into patient behaviors. With SaaS solutions like data hubs, operational insights, patient insights, S2S, and SDQ, Saama empowers AI-based clinical trial solution providers to optimize efficiency, accuracy, and effectiveness. Additionally, it aims to eliminate manual, resource-intensive activities and make clinical trials more efficient and effective.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13575&type=smp
Major Key Players of the Market:
Major companies operating in the ai-based clinical trial solution providers market report are International Business Machines Corporation, AstraZeneca, Takeda Pharmaceutical Company Limited, IQVIA Holdings Inc., BenevolentAI, Charles River Laboratories, Flatiron Health, Saama Technologies Inc., CytoReason, Median Technologies SAS, Concentro Health AI., AiCure, LLC, DEEP LENS AI Inc., GNS Healthcare, Inc., Ardigen, Koneksa Health Inc., Unlearn.AI Inc., PathAI Inc., Deep 6 AI Inc., Intelligencia Inc., Exscientia, Prometheus Biosciences, Inc., Renalytix AI plc, BioAge Labs Inc., Mendel Health Inc
AI-Based Clinical Trial Solution Providers Market 2024 Key Insights:
• The ai-based clinical trial solution providers market is expected to grow to $5.65 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%.
• Accelerated Growth in AI-Based Clinical Trial Solutions Market Driven by Rising Adoption of AI Technology
• Innovative AI-Driven Data Platforms Transforming Clinical Trials
• North America was the largest region in the AI-based clinical trial solution providers market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13575&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (http://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC’s consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
